There are 2934 resources available
4019 - Phase II study of olaparib (O) and durvalumab (D) (MEDIOLA): Updated results in patients (pts) with germline BRCA-mutated (gBRCAm) metastatic breast cancer (MBC)
Presenter: Susan Domchek
Session: Proffered Paper – Immunotherapy of cancer
Resources:
Abstract
Slides
Webcast
3250 - Personalized treatment according to geriatric assessment in 1st line recurrent and/or metastatic (R/M) Head and Neck Squamous Cell Cancer (HNSCC) patients aged 70 or over. ELAN (ELderly heAd and Neck cancer) FIT and UNFIT trials
Presenter: Joel Guigay
Session: Proffered Paper – Head and neck cancer
Resources:
Abstract
Slides
Webcast
5378 - 2nd/3rd-line Nivolumab vs Nivo plus Ipilimumab in Malignant Pleural Mesothelioma: long-term results of IFCT-1501 MAPS2 phase 2R trial with a focus on hyperprogression (HPD)
Presenter: Gerard Zalcman
Session: Proffered Paper 2 – Non-metastatic NSCLC and other thoracic malignancies (mesothelioma and thymic carcinoma)
Resources:
Abstract
Slides
Webcast
1316 - SAKK 17/16: Lurbinectedin as second or third line palliative chemotherapy in malignant pleural mesothelioma (MPM): A multi-center, single-arm Phase II trial.
Presenter: Yannis Metaxas
Session: Proffered Paper 2 – Non-metastatic NSCLC and other thoracic malignancies (mesothelioma and thymic carcinoma)
Resources:
Abstract
Slides
Webcast
803 - Durable anti-tumor activity of the multi-targeted inhibitor lenvatinib in patients with advanced or metastatic thymic carcinoma; Preliminary results from a multicenter phase II (REMORA) trial.
Presenter: Shoichi Itoh
Session: Proffered Paper 2 – Non-metastatic NSCLC and other thoracic malignancies (mesothelioma and thymic carcinoma)
Resources:
Abstract
Slides
Webcast
1432 - Double-blind Randomized Phase 2 Results Comparing Concurrent High-dose Cisplatin Chemorradiation (CRT) plus Debio 1143 or Placebo In High-risk Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN): A GORTEC Study
Presenter: Jean Bourhis
Session: Proffered Paper – Head and neck cancer
Resources:
Abstract
Slides
Webcast
Proffered Paper – Head and neck cancer - Invited Discussant 110O and 1111O
Presenter: Florence Huguet
Session: Proffered Paper – Head and neck cancer
Resources:
Slides
Webcast
Proffered Paper – Immunotherapy of cancer - Invited Discussant 1175O and 1191O
Presenter: Marleen Kok
Session: Proffered Paper – Immunotherapy of cancer
Resources:
Slides
Webcast
Drug-food interactions
Presenter: Marzia Del Re
Session: Individualised dosing of commonly used anti-cancer agents
Resources:
Slides
Webcast
Single agent immune therapy and immune combinations
Presenter: Joaquim Bellmunt
Session: Selecting and sequencing therapy in previously untreated urothelial cancer
Resources:
Slides
Webcast